“For us this is going to be a continual reassessment of ‘How can we keep adding capacity … and how can we make sure we’re two years ahead of what the demand will be,'" August Bioservices CEO Jenn Adams said.
“For us this is going to be a continual reassessment of ‘How can we keep adding capacity … and how can we make sure we’re two years ahead of what the demand will be,'" August Bioservices CEO Jenn Adams said.
